+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Plasma Protein Therapeutics Market Research Report by Product (Albumins, C1-esterase Inhibitors, and Coagulation Factors), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 247 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968904
UP TO OFF until Dec 31st 2022
The Global Plasma Protein Therapeutics Market size was estimated at USD 26.36 billion in 2021, USD 29.29 billion in 2022, and is projected to grow at a CAGR 11.23% to reach USD 49.93 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Plasma Protein Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Albumins, C1-esterase Inhibitors, Coagulation Factors, Hyperimmune Globulins, and Immunoglobulins.
  • Based on Application, the market was studied across Hereditary Angioedema, Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, and Secondary Immunodeficiency.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Plasma Protein Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Plasma Protein Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Plasma Protein Therapeutics Market, including Access Biologicals LLC, ADMA Biologics, Inc., Baxter International Inc., Bio Products Laboratory U.S.A., Inc., Biotest AG, Bruker Corporation, Cara Plasma s.r.o, China Biologic Products Holdings, Inc., CSL Behring, Grifols, S.A., Hemarus Therapeutics Limited, Kamada Ltd., Kedrion S.p.A., Laboratory Corporation of America Holdings, LFB S.A., Octapharma AG, Omega Laboratories Ltd., Plasma Protein Therapeutics Association, Plasma Technologies, LLC, PlasmaGen BioSciences Pvt. Ltd., Reliance Industries Limited, Scantibodies Laboratory, Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Plasma Protein Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Plasma Protein Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Plasma Protein Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Plasma Protein Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Plasma Protein Therapeutics Market?
6. What is the market share of the leading vendors in the Global Plasma Protein Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Plasma Protein Therapeutics Market?
Frequently Asked Questions about the Global Plasma Protein Therapeutics Market

What is the estimated value of the Global Plasma Protein Therapeutics Market?

The Global Plasma Protein Therapeutics Market was estimated to be valued at $26.36 Billion in 2021.

What is the growth rate of the Global Plasma Protein Therapeutics Market?

The growth rate of the Global Plasma Protein Therapeutics Market is 11.2%, with an estimated value of $49.93 Billion by 2027.

What is the forecasted size of the Global Plasma Protein Therapeutics Market?

The Global Plasma Protein Therapeutics Market is estimated to be worth $49.93 Billion by 2027.

Who are the key companies in the Global Plasma Protein Therapeutics Market?

Key companies in the Global Plasma Protein Therapeutics Market include Access Biologicals LLC, ADMA Biologics, Inc., Baxter International Inc., Bio Products Laboratory U.S.A., Inc., Biotest AG, Bruker Corporation, Cara Plasma s.r.o, China Biologic Products Holdings, Inc. and Grifols, S.A..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Prevalence of Autoimmune and Neurological Diseases
5.1.1.2. Need for Regular Infusions or Injections Throughout the Life of the Patient
5.1.1.3. Surging Access and Affordability of Plasma Protein Therapies for Patients
5.1.2. Restraints
5.1.2.1. Adverse Effects of Plasma Protein Therapeutics
5.1.3. Opportunities
5.1.3.1. Increasing Research and Development Activity Related to the Plasma Protein
5.1.3.2. Development of Efficient Protein Plasma Extraction/Manufacturing Process
5.1.4. Challenges
5.1.4.1. Strict Regulations Pertaining to Handling of Plasma Protein
5.2. Cumulative Impact of COVID-19
6. Plasma Protein Therapeutics Market, by Product
6.1. Introduction
6.2. Albumins
6.3. C1-Esterase Inhibitors
6.4. Coagulation Factors
6.5. Hyperimmune Globulins
6.6. Immunoglobulins
7. Plasma Protein Therapeutics Market, by Application
7.1. Introduction
7.2. Hereditary Angioedema
7.3. Idiopathic Thrombocytopenic Purpura
7.4. Primary Immunodeficiency Disorder
7.5. Secondary Immunodeficiency
8. Americas Plasma Protein Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Plasma Protein Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Plasma Protein Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. Fpnv Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Access Biologicals LLC
12.2. Adma Biologics, Inc.
12.3. Baxter International Inc.
12.4. Bio Products Laboratory U.S.A., Inc.
12.5. Biotest Ag
12.6. Bruker Corporation
12.7. Cara Plasma S.R.O
12.8. China Biologic Products Holdings, Inc.
12.9. Csl Behring
12.10. Grifols, S.A.
12.11. Hemarus Therapeutics Limited
12.12. Kamada Ltd.
12.13. Kedrion S.P.A.
12.14. Laboratory Corporation of America Holdings
12.15. Lfb S.A.
12.16. Octapharma Ag
12.17. Omega Laboratories Ltd.
12.18. Plasma Protein Therapeutics Association
12.19. Plasma Technologies, LLC
12.20. Plasmagen Biosciences Pvt. Ltd.
12.21. Reliance Industries Limited
12.22. Scantibodies Laboratory, Inc.
12.23. Takeda Pharmaceutical Company Limited
12.24. Thermo Fisher Scientific, Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET DYNAMICS
FIGURE 8. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 22. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2027
FIGURE 24. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 34. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 36. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 42. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2027
FIGURE 44. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 46. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 48. AUSTRALIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. CHINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. INDIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. INDONESIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. JAPAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. MALAYSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. PHILIPPINES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. SINGAPORE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. SOUTH KOREA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. TAIWAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. THAILAND PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 63. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. NETHERLANDS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. QATAR PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SOUTH AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 75. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 56. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 58. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 59. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 61. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 62. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 64. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 65. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 67. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 76. AUSTRALIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. AUSTRALIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 78. AUSTRALIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 79. CHINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. CHINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 81. CHINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 82. INDIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. INDIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 84. INDIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 85. INDONESIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. INDONESIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 87. INDONESIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 88. JAPAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. JAPAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 90. JAPAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 91. MALAYSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. MALAYSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 93. MALAYSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 94. PHILIPPINES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. PHILIPPINES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 96. PHILIPPINES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 97. SINGAPORE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. SINGAPORE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 99. SINGAPORE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 100. SOUTH KOREA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. SOUTH KOREA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 102. SOUTH KOREA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 103. TAIWAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. TAIWAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 105. TAIWAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 106. THAILAND PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. THAILAND PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 108. THAILAND PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 113. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 115. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 116. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 118. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 119. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 121. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 122. NETHERLANDS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. NETHERLANDS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 124. NETHERLANDS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 125. QATAR PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. QATAR PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 127. QATAR PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 128. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 130. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 131. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 133. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 134. SOUTH AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. SOUTH AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 136. SOUTH AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 137. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 139. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 143. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 145. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 147. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 148. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 149. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET RANKING
TABLE 150. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 151. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 152. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 153. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 154. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 155. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 156. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Access Biologicals LLC
  • ADMA Biologics, Inc.
  • Baxter International Inc.
  • Bio Products Laboratory U.S.A., Inc.
  • Biotest AG
  • Bruker Corporation
  • Cara Plasma s.r.o
  • China Biologic Products Holdings, Inc.
  • CSL Behring
  • Grifols, S.A.
  • Hemarus Therapeutics Limited
  • Kamada Ltd.
  • Kedrion S.p.A.
  • Laboratory Corporation of America Holdings
  • LFB S.A.
  • Octapharma AG
  • Omega Laboratories Ltd.
  • Plasma Protein Therapeutics Association
  • Plasma Technologies, LLC
  • PlasmaGen BioSciences Pvt. Ltd.
  • Reliance Industries Limited
  • Scantibodies Laboratory, Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...